MET and melanoma: In this study, we investigated the interplay between HGF, its receptor c-met, and an ROS source (Nox4) in early, late, and nonmetastatic melanoma patients, looking at cellular ROS modulation through the inhibition of HGF/c-met and Nox4 in vitro [21].